This independent HPLC-UV/VIS lab test confirms GLP3-R (Retatrutide) 50mg from Licensed Peptides at 99.50% purity. The analysis was conducted by Vanguard Laboratory on December 10, 2025. The tested quantity of 59.11mg exceeds the stated label claim of 50mg, indicating consistent formulation and manufacturing precision.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for metabolic regulation, weight management, and glycemic control. A purity level of 99.50% demonstrates high-grade synthesis with minimal contamination. The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.